Suchergebnisse - "Abreu, Maria"

PubPharm (6)

1

ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1-Mutant Breast Cancer

enthalten in: Cancer discovery | 2024

von Kingston, B. | Pearson, A. | Herrera-Abreu, M. | +14

2

Triplet Therapy with Palbociclib, Taselisib, and Fulvestrant in PIK3CA-Mutant Breast Cancer and Doublet Palbociclib and Taselisib in Pathway-Mutant Solid Cancers

enthalten in: Cancer discovery | 2021

von Pascual, J. | Lim, J. | Macpherson, I. | +25

CommentOn: Cancer Discov. 2021 Jan;11(1):1-3. - PMID 34003778

3

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

enthalten in: Cancer discovery | 2016

von Pearson, A. | Smyth, E. | Babina, I. | +24

4

High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial

enthalten in: Cancer discovery | 2016

von Pearson, A. | Smyth, E. | Babina, I. | +24

5

Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer

enthalten in: Cancer discovery | 2013

von Herrera-Abreu, M. | Pearson, A. | Campbell, J. | +4

6

Parallel RNA Interference Screens Identify EGFR Activation as an Escape Mechanism in FGFR3-Mutant Cancer

enthalten in: Cancer discovery | 2013

von Herrera-Abreu, M. | Pearson, A. | Campbell, J. | +4

1
[1]